nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—AR—type 2 diabetes mellitus	0.19	0.576	CbGaD
Enzalutamide—CYP3A4—type 2 diabetes mellitus	0.0749	0.226	CbGaD
Enzalutamide—ALB—type 2 diabetes mellitus	0.0653	0.198	CbGaD
Enzalutamide—ALB—Gliclazide—type 2 diabetes mellitus	0.0198	0.0401	CbGbCtD
Enzalutamide—ALB—Repaglinide—type 2 diabetes mellitus	0.0186	0.0377	CbGbCtD
Enzalutamide—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.018	0.0365	CbGbCtD
Enzalutamide—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0155	0.0315	CbGbCtD
Enzalutamide—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0144	0.0291	CbGbCtD
Enzalutamide—ALB—Valsartan—type 2 diabetes mellitus	0.0137	0.0278	CbGbCtD
Enzalutamide—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0136	0.0277	CbGbCtD
Enzalutamide—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.013	0.0264	CbGbCtD
Enzalutamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0128	0.026	CbGbCtD
Enzalutamide—ALB—Nateglinide—type 2 diabetes mellitus	0.0127	0.0258	CbGbCtD
Enzalutamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0125	0.0254	CbGbCtD
Enzalutamide—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0122	0.0247	CbGbCtD
Enzalutamide—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0243	CbGbCtD
Enzalutamide—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0116	0.0235	CbGbCtD
Enzalutamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0115	0.0233	CbGbCtD
Enzalutamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0109	0.0221	CbGbCtD
Enzalutamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0109	0.0221	CbGbCtD
Enzalutamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0107	0.0216	CbGbCtD
Enzalutamide—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0102	0.0208	CbGbCtD
Enzalutamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0101	0.0204	CbGbCtD
Enzalutamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00971	0.0197	CbGbCtD
Enzalutamide—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00944	0.0191	CbGbCtD
Enzalutamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00906	0.0184	CbGbCtD
Enzalutamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00906	0.0184	CbGbCtD
Enzalutamide—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00879	0.0178	CbGbCtD
Enzalutamide—ALB—Glyburide—type 2 diabetes mellitus	0.0086	0.0175	CbGbCtD
Enzalutamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00836	0.017	CbGbCtD
Enzalutamide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00828	0.0168	CbGbCtD
Enzalutamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00817	0.0166	CbGbCtD
Enzalutamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00807	0.0164	CbGbCtD
Enzalutamide—ALB—Losartan—type 2 diabetes mellitus	0.00787	0.016	CbGbCtD
Enzalutamide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00764	0.0155	CbGbCtD
Enzalutamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00738	0.015	CbGbCtD
Enzalutamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00729	0.0148	CbGbCtD
Enzalutamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00687	0.0139	CbGbCtD
Enzalutamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00666	0.0135	CbGbCtD
Enzalutamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00658	0.0134	CbGbCtD
Enzalutamide—CYP3A5—Losartan—type 2 diabetes mellitus	0.00632	0.0128	CbGbCtD
Enzalutamide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00628	0.0127	CbGbCtD
Enzalutamide—CYP2C8—Losartan—type 2 diabetes mellitus	0.00608	0.0123	CbGbCtD
Enzalutamide—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00604	0.0123	CbGbCtD
Enzalutamide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00602	0.0122	CbGbCtD
Enzalutamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00582	0.0118	CbGbCtD
Enzalutamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00558	0.0113	CbGbCtD
Enzalutamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00527	0.0107	CbGbCtD
Enzalutamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.0051	0.0104	CbGbCtD
Enzalutamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00464	0.00941	CbGbCtD
Enzalutamide—ABCB1—Glyburide—type 2 diabetes mellitus	0.0045	0.00913	CbGbCtD
Enzalutamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00424	0.00861	CbGbCtD
Enzalutamide—ABCB1—Losartan—type 2 diabetes mellitus	0.00412	0.00835	CbGbCtD
Enzalutamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00399	0.0081	CbGbCtD
Enzalutamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00383	0.00777	CbGbCtD
Enzalutamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00383	0.00777	CbGbCtD
Enzalutamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00362	0.00734	CbGbCtD
Enzalutamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0027	0.00547	CbGbCtD
Enzalutamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00247	0.005	CbGbCtD
Enzalutamide—Bicalutamide—AR—type 2 diabetes mellitus	0.00155	0.491	CrCbGaD
Enzalutamide—Nilutamide—AR—type 2 diabetes mellitus	0.001	0.316	CrCbGaD
Enzalutamide—Bicalutamide—CYP3A4—type 2 diabetes mellitus	0.000611	0.193	CrCbGaD
Enzalutamide—AR—penis—type 2 diabetes mellitus	0.000416	0.227	CbGeAlD
Enzalutamide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00022	0.00196	CcSEcCtD
Enzalutamide—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00196	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.00022	0.00196	CcSEcCtD
Enzalutamide—Infestation NOS—Metformin—type 2 diabetes mellitus	0.000218	0.00195	CcSEcCtD
Enzalutamide—Infestation—Metformin—type 2 diabetes mellitus	0.000218	0.00195	CcSEcCtD
Enzalutamide—Insomnia—Glipizide—type 2 diabetes mellitus	0.000218	0.00194	CcSEcCtD
Enzalutamide—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00194	CcSEcCtD
Enzalutamide—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000216	0.00193	CcSEcCtD
Enzalutamide—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.000216	0.00193	CcSEcCtD
Enzalutamide—Rhinitis—Valsartan—type 2 diabetes mellitus	0.000216	0.00193	CcSEcCtD
Enzalutamide—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00192	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.000215	0.00192	CcSEcCtD
Enzalutamide—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00191	CcSEcCtD
Enzalutamide—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.000214	0.00191	CcSEcCtD
Enzalutamide—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000213	0.0019	CcSEcCtD
Enzalutamide—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.000212	0.00189	CcSEcCtD
Enzalutamide—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000211	0.00188	CcSEcCtD
Enzalutamide—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000211	0.00188	CcSEcCtD
Enzalutamide—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00188	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00188	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00187	CcSEcCtD
Enzalutamide—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.00021	0.00187	CcSEcCtD
Enzalutamide—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.00021	0.00187	CcSEcCtD
Enzalutamide—Bronchitis—Losartan—type 2 diabetes mellitus	0.000209	0.00187	CcSEcCtD
Enzalutamide—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000209	0.00186	CcSEcCtD
Enzalutamide—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000209	0.00186	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000208	0.00186	CcSEcCtD
Enzalutamide—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000207	0.00185	CcSEcCtD
Enzalutamide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000206	0.00184	CcSEcCtD
Enzalutamide—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000205	0.00183	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00182	CcSEcCtD
Enzalutamide—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000203	0.00181	CcSEcCtD
Enzalutamide—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000203	0.00181	CcSEcCtD
Enzalutamide—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00181	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000202	0.0018	CcSEcCtD
Enzalutamide—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000202	0.0018	CcSEcCtD
Enzalutamide—Infection—Bromocriptine—type 2 diabetes mellitus	0.000202	0.0018	CcSEcCtD
Enzalutamide—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000201	0.00179	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000199	0.00178	CcSEcCtD
Enzalutamide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000199	0.00178	CcSEcCtD
Enzalutamide—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000199	0.00178	CcSEcCtD
Enzalutamide—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00177	CcSEcCtD
Enzalutamide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000197	0.00176	CcSEcCtD
Enzalutamide—Back pain—Gliclazide—type 2 diabetes mellitus	0.000197	0.00176	CcSEcCtD
Enzalutamide—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00176	CcSEcCtD
Enzalutamide—Convulsion—Glyburide—type 2 diabetes mellitus	0.000197	0.00176	CcSEcCtD
Enzalutamide—Rhinitis—Metformin—type 2 diabetes mellitus	0.000197	0.00175	CcSEcCtD
Enzalutamide—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000195	0.00174	CcSEcCtD
Enzalutamide—Pneumonia—Losartan—type 2 diabetes mellitus	0.000195	0.00174	CcSEcCtD
Enzalutamide—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000195	0.00174	CcSEcCtD
Enzalutamide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000195	0.00174	CcSEcCtD
Enzalutamide—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.000194	0.00173	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000194	0.00173	CcSEcCtD
Enzalutamide—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000194	0.00173	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00173	CcSEcCtD
Enzalutamide—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000193	0.00173	CcSEcCtD
Enzalutamide—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00172	CcSEcCtD
Enzalutamide—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000193	0.00172	CcSEcCtD
Enzalutamide—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000193	0.00172	CcSEcCtD
Enzalutamide—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000189	0.00168	CcSEcCtD
Enzalutamide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000188	0.00168	CcSEcCtD
Enzalutamide—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000186	0.00166	CcSEcCtD
Enzalutamide—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000186	0.00166	CcSEcCtD
Enzalutamide—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00164	CcSEcCtD
Enzalutamide—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000184	0.00164	CcSEcCtD
Enzalutamide—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00164	CcSEcCtD
Enzalutamide—Epistaxis—Losartan—type 2 diabetes mellitus	0.000183	0.00163	CcSEcCtD
Enzalutamide—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000183	0.00163	CcSEcCtD
Enzalutamide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000183	0.00163	CcSEcCtD
Enzalutamide—Headache—Repaglinide—type 2 diabetes mellitus	0.000182	0.00163	CcSEcCtD
Enzalutamide—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000182	0.00163	CcSEcCtD
Enzalutamide—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00163	CcSEcCtD
Enzalutamide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000182	0.00162	CcSEcCtD
Enzalutamide—Sinusitis—Losartan—type 2 diabetes mellitus	0.000182	0.00162	CcSEcCtD
Enzalutamide—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000182	0.00162	CcSEcCtD
Enzalutamide—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000182	0.00162	CcSEcCtD
Enzalutamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000182	0.00162	CcSEcCtD
Enzalutamide—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000181	0.00162	CcSEcCtD
Enzalutamide—Back pain—Valsartan—type 2 diabetes mellitus	0.000181	0.00162	CcSEcCtD
Enzalutamide—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000179	0.0016	CcSEcCtD
Enzalutamide—Back pain—Orlistat—type 2 diabetes mellitus	0.000179	0.0016	CcSEcCtD
Enzalutamide—Angiopathy—Metformin—type 2 diabetes mellitus	0.000178	0.00159	CcSEcCtD
Enzalutamide—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000177	0.00158	CcSEcCtD
Enzalutamide—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000176	0.00157	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00156	CcSEcCtD
Enzalutamide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00156	CcSEcCtD
Enzalutamide—Rhinitis—Losartan—type 2 diabetes mellitus	0.000175	0.00156	CcSEcCtD
Enzalutamide—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000174	0.00156	CcSEcCtD
Enzalutamide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000174	0.00155	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000173	0.00155	CcSEcCtD
Enzalutamide—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000173	0.00155	CcSEcCtD
Enzalutamide—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000173	0.00154	CcSEcCtD
Enzalutamide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000173	0.00154	CcSEcCtD
Enzalutamide—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000173	0.00154	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000173	0.00154	CcSEcCtD
Enzalutamide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000172	0.00154	CcSEcCtD
Enzalutamide—Pruritus—Glipizide—type 2 diabetes mellitus	0.00017	0.00152	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000169	0.00151	CcSEcCtD
Enzalutamide—Vertigo—Valsartan—type 2 diabetes mellitus	0.000168	0.0015	CcSEcCtD
Enzalutamide—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000168	0.0015	CcSEcCtD
Enzalutamide—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000167	0.00149	CcSEcCtD
Enzalutamide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000166	0.00148	CcSEcCtD
Enzalutamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000166	0.00148	CcSEcCtD
Enzalutamide—Infection—Gliclazide—type 2 diabetes mellitus	0.000165	0.00148	CcSEcCtD
Enzalutamide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000165	0.00147	CcSEcCtD
Enzalutamide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000163	0.00146	CcSEcCtD
Enzalutamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000163	0.00145	CcSEcCtD
Enzalutamide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000162	0.00144	CcSEcCtD
Enzalutamide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000161	0.00144	CcSEcCtD
Enzalutamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00143	CcSEcCtD
Enzalutamide—Convulsion—Orlistat—type 2 diabetes mellitus	0.00016	0.00143	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00016	0.00143	CcSEcCtD
Enzalutamide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00016	0.00142	CcSEcCtD
Enzalutamide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000159	0.00142	CcSEcCtD
Enzalutamide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000159	0.00142	CcSEcCtD
Enzalutamide—Anxiety—Valsartan—type 2 diabetes mellitus	0.000159	0.00142	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000158	0.00141	CcSEcCtD
Enzalutamide—Angiopathy—Losartan—type 2 diabetes mellitus	0.000158	0.00141	CcSEcCtD
Enzalutamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000158	0.00141	CcSEcCtD
Enzalutamide—Anxiety—Orlistat—type 2 diabetes mellitus	0.000157	0.0014	CcSEcCtD
Enzalutamide—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000157	0.0014	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000157	0.0014	CcSEcCtD
Enzalutamide—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000156	0.00139	CcSEcCtD
Enzalutamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000154	0.00137	CcSEcCtD
Enzalutamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00137	CcSEcCtD
Enzalutamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000153	0.00136	CcSEcCtD
Enzalutamide—Infection—Valsartan—type 2 diabetes mellitus	0.000152	0.00136	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000152	0.00135	CcSEcCtD
Enzalutamide—Headache—Glipizide—type 2 diabetes mellitus	0.000151	0.00135	CcSEcCtD
Enzalutamide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000151	0.00134	CcSEcCtD
Enzalutamide—Infection—Orlistat—type 2 diabetes mellitus	0.00015	0.00134	CcSEcCtD
Enzalutamide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00015	0.00134	CcSEcCtD
Enzalutamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00015	0.00134	CcSEcCtD
Enzalutamide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00015	0.00133	CcSEcCtD
Enzalutamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000149	0.00133	CcSEcCtD
Enzalutamide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000149	0.00133	CcSEcCtD
Enzalutamide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000148	0.00132	CcSEcCtD
Enzalutamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000148	0.00132	CcSEcCtD
Enzalutamide—Hypertension—Metformin—type 2 diabetes mellitus	0.000147	0.00131	CcSEcCtD
Enzalutamide—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000147	0.00131	CcSEcCtD
Enzalutamide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000147	0.00131	CcSEcCtD
Enzalutamide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000147	0.00131	CcSEcCtD
Enzalutamide—Back pain—Losartan—type 2 diabetes mellitus	0.000147	0.00131	CcSEcCtD
Enzalutamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000146	0.0013	CcSEcCtD
Enzalutamide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000145	0.00129	CcSEcCtD
Enzalutamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000145	0.00129	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000144	0.00129	CcSEcCtD
Enzalutamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000144	0.00129	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000144	0.00128	CcSEcCtD
Enzalutamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000144	0.00128	CcSEcCtD
Enzalutamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000141	0.00126	CcSEcCtD
Enzalutamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00125	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000139	0.00124	CcSEcCtD
Enzalutamide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000139	0.00124	CcSEcCtD
Enzalutamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000139	0.00124	CcSEcCtD
Enzalutamide—Infection—Metformin—type 2 diabetes mellitus	0.000138	0.00123	CcSEcCtD
Enzalutamide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000138	0.00123	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000138	0.00123	CcSEcCtD
Enzalutamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000137	0.00123	CcSEcCtD
Enzalutamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000137	0.00122	CcSEcCtD
Enzalutamide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000137	0.00122	CcSEcCtD
Enzalutamide—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000137	0.00122	CcSEcCtD
Enzalutamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000137	0.00122	CcSEcCtD
Enzalutamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000136	0.00122	CcSEcCtD
Enzalutamide—Vertigo—Losartan—type 2 diabetes mellitus	0.000136	0.00122	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000136	0.00122	CcSEcCtD
Enzalutamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000136	0.00121	CcSEcCtD
Enzalutamide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000136	0.00121	CcSEcCtD
Enzalutamide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000135	0.00121	CcSEcCtD
Enzalutamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000134	0.0012	CcSEcCtD
Enzalutamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000133	0.00119	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000132	0.00118	CcSEcCtD
Enzalutamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000132	0.00118	CcSEcCtD
Enzalutamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000131	0.00117	CcSEcCtD
Enzalutamide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.00117	CcSEcCtD
Enzalutamide—Infection—Irbesartan—type 2 diabetes mellitus	0.000131	0.00117	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000131	0.00116	CcSEcCtD
Enzalutamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.00013	0.00116	CcSEcCtD
Enzalutamide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000129	0.00115	CcSEcCtD
Enzalutamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000129	0.00115	CcSEcCtD
Enzalutamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000129	0.00115	CcSEcCtD
Enzalutamide—Anxiety—Losartan—type 2 diabetes mellitus	0.000129	0.00115	CcSEcCtD
Enzalutamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000128	0.00114	CcSEcCtD
Enzalutamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000127	0.00113	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000127	0.00113	CcSEcCtD
Enzalutamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000127	0.00113	CcSEcCtD
Enzalutamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000125	0.00112	CcSEcCtD
Enzalutamide—Infection—Losartan—type 2 diabetes mellitus	0.000123	0.0011	CcSEcCtD
Enzalutamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
Enzalutamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000121	0.00108	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Enzalutamide—Fatigue—Metformin—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Enzalutamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000119	0.00107	CcSEcCtD
Enzalutamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
Enzalutamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000118	0.00105	CcSEcCtD
Enzalutamide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000117	0.00104	CcSEcCtD
Enzalutamide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
Enzalutamide—Headache—Glyburide—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
Enzalutamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000114	0.00101	CcSEcCtD
Enzalutamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Enzalutamide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000113	0.001	CcSEcCtD
Enzalutamide—Insomnia—Losartan—type 2 diabetes mellitus	0.000112	0.000998	CcSEcCtD
Enzalutamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000111	0.000991	CcSEcCtD
Enzalutamide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000111	0.000987	CcSEcCtD
Enzalutamide—Anxiety—Ramipril—type 2 diabetes mellitus	0.00011	0.000984	CcSEcCtD
Enzalutamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00011	0.000982	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00011	0.000981	CcSEcCtD
Enzalutamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.00011	0.000979	CcSEcCtD
Enzalutamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000108	0.000968	CcSEcCtD
Enzalutamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000108	0.000966	CcSEcCtD
Enzalutamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000107	0.000954	CcSEcCtD
Enzalutamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000107	0.000952	CcSEcCtD
Enzalutamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000105	0.000934	CcSEcCtD
Enzalutamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000104	0.000931	CcSEcCtD
Enzalutamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000104	0.000928	CcSEcCtD
Enzalutamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000104	0.000927	CcSEcCtD
Enzalutamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000103	0.000923	CcSEcCtD
Enzalutamide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000103	0.000919	CcSEcCtD
Enzalutamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000101	0.000903	CcSEcCtD
Enzalutamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.0001	0.000892	CcSEcCtD
Enzalutamide—Asthenia—Metformin—type 2 diabetes mellitus	0.0001	0.000892	CcSEcCtD
Enzalutamide—Pruritus—Metformin—type 2 diabetes mellitus	9.86e-05	0.000879	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000862	CcSEcCtD
Enzalutamide—Insomnia—Ramipril—type 2 diabetes mellitus	9.6e-05	0.000856	CcSEcCtD
Enzalutamide—Headache—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000855	CcSEcCtD
Enzalutamide—Diarrhoea—Metformin—type 2 diabetes mellitus	9.53e-05	0.00085	CcSEcCtD
Enzalutamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	9.53e-05	0.00085	CcSEcCtD
Enzalutamide—Headache—Orlistat—type 2 diabetes mellitus	9.47e-05	0.000845	CcSEcCtD
Enzalutamide—Asthenia—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000842	CcSEcCtD
Enzalutamide—Pruritus—Irbesartan—type 2 diabetes mellitus	9.3e-05	0.00083	CcSEcCtD
Enzalutamide—Dizziness—Metformin—type 2 diabetes mellitus	9.21e-05	0.000822	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.16e-05	0.000817	CcSEcCtD
Enzalutamide—Fatigue—Ramipril—type 2 diabetes mellitus	9.15e-05	0.000816	CcSEcCtD
Enzalutamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9e-05	0.000803	CcSEcCtD
Enzalutamide—Asthenia—Losartan—type 2 diabetes mellitus	8.88e-05	0.000792	CcSEcCtD
Enzalutamide—Pruritus—Losartan—type 2 diabetes mellitus	8.75e-05	0.000781	CcSEcCtD
Enzalutamide—Headache—Metformin—type 2 diabetes mellitus	8.73e-05	0.000779	CcSEcCtD
Enzalutamide—Dizziness—Irbesartan—type 2 diabetes mellitus	8.69e-05	0.000776	CcSEcCtD
Enzalutamide—Diarrhoea—Losartan—type 2 diabetes mellitus	8.47e-05	0.000755	CcSEcCtD
Enzalutamide—Headache—Irbesartan—type 2 diabetes mellitus	8.24e-05	0.000735	CcSEcCtD
Enzalutamide—Dizziness—Losartan—type 2 diabetes mellitus	8.18e-05	0.00073	CcSEcCtD
Enzalutamide—Headache—Losartan—type 2 diabetes mellitus	7.75e-05	0.000692	CcSEcCtD
Enzalutamide—Asthenia—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000679	CcSEcCtD
Enzalutamide—Pruritus—Ramipril—type 2 diabetes mellitus	7.51e-05	0.00067	CcSEcCtD
Enzalutamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000648	CcSEcCtD
Enzalutamide—Dizziness—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000626	CcSEcCtD
Enzalutamide—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	6.75e-05	0.0369	CbGeAlD
Enzalutamide—AR—cardiovascular system—type 2 diabetes mellitus	6.68e-05	0.0365	CbGeAlD
Enzalutamide—Headache—Ramipril—type 2 diabetes mellitus	6.65e-05	0.000593	CcSEcCtD
Enzalutamide—AR—kidney—type 2 diabetes mellitus	6.54e-05	0.0357	CbGeAlD
Enzalutamide—AR—cortex of kidney—type 2 diabetes mellitus	6.37e-05	0.0348	CbGeAlD
Enzalutamide—AR—adipose tissue—type 2 diabetes mellitus	5.89e-05	0.0322	CbGeAlD
Enzalutamide—CYP3A5—nephron tubule—type 2 diabetes mellitus	5.43e-05	0.0297	CbGeAlD
Enzalutamide—CYP2B6—nephron tubule—type 2 diabetes mellitus	5.4e-05	0.0295	CbGeAlD
Enzalutamide—CYP2C8—kidney—type 2 diabetes mellitus	5.29e-05	0.0289	CbGeAlD
Enzalutamide—CYP2B6—cardiovascular system—type 2 diabetes mellitus	4.85e-05	0.0265	CbGeAlD
Enzalutamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	4.8e-05	0.0262	CbGeAlD
Enzalutamide—CYP3A5—kidney—type 2 diabetes mellitus	4.77e-05	0.0261	CbGeAlD
Enzalutamide—ALB—liver—type 2 diabetes mellitus	4.76e-05	0.026	CbGeAlD
Enzalutamide—CYP2B6—kidney—type 2 diabetes mellitus	4.74e-05	0.0259	CbGeAlD
Enzalutamide—CYP3A5—pancreas—type 2 diabetes mellitus	4.74e-05	0.0259	CbGeAlD
Enzalutamide—CYP3A5—cortex of kidney—type 2 diabetes mellitus	4.65e-05	0.0254	CbGeAlD
Enzalutamide—CYP3A5—adipose tissue—type 2 diabetes mellitus	4.3e-05	0.0235	CbGeAlD
Enzalutamide—AR—liver—type 2 diabetes mellitus	4.13e-05	0.0226	CbGeAlD
Enzalutamide—CYP2C19—liver—type 2 diabetes mellitus	3.83e-05	0.0209	CbGeAlD
Enzalutamide—ABCB1—islet of Langerhans—type 2 diabetes mellitus	3.58e-05	0.0196	CbGeAlD
Enzalutamide—CYP3A4—kidney—type 2 diabetes mellitus	3.58e-05	0.0196	CbGeAlD
Enzalutamide—CYP2D6—kidney—type 2 diabetes mellitus	3.53e-05	0.0193	CbGeAlD
Enzalutamide—CYP2C8—liver—type 2 diabetes mellitus	3.34e-05	0.0183	CbGeAlD
Enzalutamide—ABCB1—retina—type 2 diabetes mellitus	3.06e-05	0.0167	CbGeAlD
Enzalutamide—CYP3A5—liver—type 2 diabetes mellitus	3.02e-05	0.0165	CbGeAlD
Enzalutamide—CYP2B6—liver—type 2 diabetes mellitus	3e-05	0.0164	CbGeAlD
Enzalutamide—CYP2C9—liver—type 2 diabetes mellitus	2.97e-05	0.0162	CbGeAlD
Enzalutamide—ABCB1—nephron tubule—type 2 diabetes mellitus	2.89e-05	0.0158	CbGeAlD
Enzalutamide—ABCB1—cardiovascular system—type 2 diabetes mellitus	2.59e-05	0.0142	CbGeAlD
Enzalutamide—ABCB1—kidney—type 2 diabetes mellitus	2.54e-05	0.0139	CbGeAlD
Enzalutamide—ABCB1—pancreas—type 2 diabetes mellitus	2.52e-05	0.0138	CbGeAlD
Enzalutamide—ABCB1—cortex of kidney—type 2 diabetes mellitus	2.47e-05	0.0135	CbGeAlD
Enzalutamide—ABCB1—adipose tissue—type 2 diabetes mellitus	2.29e-05	0.0125	CbGeAlD
Enzalutamide—CYP3A4—liver—type 2 diabetes mellitus	2.26e-05	0.0124	CbGeAlD
Enzalutamide—CYP2D6—liver—type 2 diabetes mellitus	2.23e-05	0.0122	CbGeAlD
Enzalutamide—ABCB1—liver—type 2 diabetes mellitus	1.6e-05	0.00876	CbGeAlD
Enzalutamide—ALB—Hemostasis—SRC—type 2 diabetes mellitus	3.97e-06	6.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.97e-06	6.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.97e-06	6.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.97e-06	6.68e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	3.94e-06	6.64e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.94e-06	6.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	3.93e-06	6.62e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	3.92e-06	6.59e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.87e-06	6.52e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.87e-06	6.52e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	3.87e-06	6.52e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.87e-06	6.51e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.86e-06	6.5e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.86e-06	6.5e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.86e-06	6.5e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.86e-06	6.5e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.85e-06	6.48e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.83e-06	6.45e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.83e-06	6.45e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	3.83e-06	6.44e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.82e-06	6.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.81e-06	6.42e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.81e-06	6.41e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GNB3—type 2 diabetes mellitus	3.81e-06	6.41e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.81e-06	6.41e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.81e-06	6.41e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	3.79e-06	6.39e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	3.78e-06	6.36e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.77e-06	6.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.77e-06	6.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.76e-06	6.34e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAT—type 2 diabetes mellitus	3.74e-06	6.3e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.71e-06	6.25e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.71e-06	6.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.7e-06	6.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.68e-06	6.2e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.66e-06	6.17e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.65e-06	6.15e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.65e-06	6.15e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.65e-06	6.15e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.64e-06	6.13e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOB—type 2 diabetes mellitus	3.63e-06	6.12e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	3.63e-06	6.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.62e-06	6.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.62e-06	6.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.56e-06	5.99e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.55e-06	5.98e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.55e-06	5.98e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-06	5.95e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.53e-06	5.94e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.49e-06	5.87e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.47e-06	5.84e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.47e-06	5.84e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.45e-06	5.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.45e-06	5.8e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.44e-06	5.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.42e-06	5.76e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.42e-06	5.76e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.42e-06	5.75e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.41e-06	5.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.4e-06	5.73e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.4e-06	5.73e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.4e-06	5.72e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.39e-06	5.7e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-06	5.7e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.38e-06	5.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.36e-06	5.66e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.34e-06	5.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.34e-06	5.62e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.34e-06	5.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.32e-06	5.6e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.31e-06	5.58e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.3e-06	5.55e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.28e-06	5.52e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.27e-06	5.51e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.26e-06	5.49e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	5.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.21e-06	5.41e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.18e-06	5.36e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.17e-06	5.34e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.15e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.15e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.15e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.15e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.14e-06	5.29e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.13e-06	5.27e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	5.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.12e-06	5.25e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.12e-06	5.25e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.11e-06	5.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.1e-06	5.23e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.1e-06	5.21e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.09e-06	5.2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.09e-06	5.2e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.08e-06	5.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.07e-06	5.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.07e-06	5.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.07e-06	5.17e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	5.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.06e-06	5.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.05e-06	5.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.05e-06	5.13e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.04e-06	5.12e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.04e-06	5.12e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.01e-06	5.07e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3e-06	5.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3e-06	5.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.98e-06	5.03e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.98e-06	5.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.97e-06	5.01e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AGT—type 2 diabetes mellitus	2.97e-06	5e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.97e-06	4.99e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.96e-06	4.98e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.96e-06	4.98e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.95e-06	4.97e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	2.94e-06	4.95e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.93e-06	4.94e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.92e-06	4.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.92e-06	4.92e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CALM1—type 2 diabetes mellitus	2.92e-06	4.91e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.92e-06	4.91e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—type 2 diabetes mellitus	2.91e-06	4.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.89e-06	4.87e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.89e-06	4.87e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.89e-06	4.86e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.88e-06	4.86e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	4.84e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.86e-06	4.82e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.85e-06	4.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.84e-06	4.78e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.8e-06	4.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.8e-06	4.72e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.79e-06	4.7e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.78e-06	4.68e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.77e-06	4.66e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—type 2 diabetes mellitus	2.77e-06	4.66e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.75e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.75e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.75e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.75e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.74e-06	4.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.72e-06	4.58e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.71e-06	4.55e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.7e-06	4.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.7e-06	4.54e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.69e-06	4.52e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.68e-06	4.52e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.68e-06	4.51e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.66e-06	4.49e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.66e-06	4.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.64e-06	4.45e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.62e-06	4.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-06	4.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.61e-06	4.39e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.6e-06	4.38e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.59e-06	4.36e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.59e-06	4.36e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-06	4.34e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.58e-06	4.34e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.56e-06	4.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.56e-06	4.3e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.55e-06	4.29e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.55e-06	4.29e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	4.26e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.53e-06	4.26e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.53e-06	4.26e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.53e-06	4.26e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.52e-06	4.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.52e-06	4.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.51e-06	4.22e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.5e-06	4.21e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.49e-06	4.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.49e-06	4.19e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	4.18e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.47e-06	4.16e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.45e-06	4.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.43e-06	4.09e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.41e-06	4.06e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.4e-06	4.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.39e-06	4.02e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.39e-06	4.02e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.39e-06	4.02e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.38e-06	4.01e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.37e-06	4e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.37e-06	3.98e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.35e-06	3.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-06	3.9e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.29e-06	3.86e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-06	3.83e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.23e-06	3.75e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.22e-06	3.74e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-06	3.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-06	3.69e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	3.67e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	3.67e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.18e-06	3.66e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.09e-06	3.52e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.07e-06	3.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.06e-06	3.46e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.06e-06	3.46e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.05e-06	3.45e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.05e-06	3.45e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.04e-06	3.44e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.03e-06	3.42e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.02e-06	3.4e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2e-06	3.37e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2e-06	3.36e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	3.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.96e-06	3.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.96e-06	3.29e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.96e-06	3.29e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.91e-06	3.21e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.91e-06	3.21e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.91e-06	3.21e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.88e-06	3.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.87e-06	3.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.86e-06	3.14e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.83e-06	3.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.83e-06	3.08e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.8e-06	3.03e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.8e-06	3.03e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	3.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-06	3e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-06	3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.78e-06	3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.76e-06	2.96e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.75e-06	2.94e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.69e-06	2.84e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.65e-06	2.78e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	2.77e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-06	2.75e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.6e-06	2.7e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-06	2.65e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.57e-06	2.64e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.55e-06	2.61e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.37e-06	2.3e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.34e-06	2.26e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.23e-06	2.07e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-06	1.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.08e-06	1.81e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.7e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	1.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.99e-07	1.51e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.77e-07	1.48e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.27e-07	1.39e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-07	1.38e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.41e-07	9.1e-06	CbGpPWpGaD
